Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
FLATICON 60MG CHEW 30TAB
- Sku : I-017045
Key features
FLATICON 60MG CHEW 30TAB is a chewable tablet containing simethicone 60 mg as the active ingredient. It acts as a surface-active antifoaming agent that lowers the surface tension of gas bubbles in the gastrointestinal tract, causing them to coalesce and be eliminated more easily. Indicated for over-the-counter symptomatic relief of gastrointestinal gas, including bloating, pressure, fullness and discomfort, and for postoperative gas discomfort. Available OTC in a pack of 30 chewable tablets.- Brand: FLATICON
- Active Ingredient: SIMETHICONE 60mg
- Strength: 60mg
- Dosage Form: Chewable tablet
- Pack Size: 30 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Nervous System
- Drug Class: Antiflatulent / Defoaming Agent
- Manufacturer: RIYADH PHARMA
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1111246175
- Shelf Life: 36 months
- Storage: Store below 30°C , Protect from light and moisture
- Gi Condition: Flatulence/Gas
Frequently bought together
Indications
Approved Uses
OTC symptomatic relief of gastrointestinal gas (flatulence) including bloating, pressure, fullness, and discomfort; may be used for postoperative gas discomfort.
Off-Label Uses
Adjunct to improve mucosal visualization by reducing foam/bubbles during upper GI endoscopy; may be used to reduce gas artifacts before abdominal imaging (institution/protocol dependent).
Dosage & Administration
Dosing by Condition
Gas/flatulence (chewable tablets): Adults and children ≥12 years: 60-125 mg after meals and at bedtime (up to 4 times daily); maximum daily dose depends on product labeling (commonly not exceeding 500 mg/day for many OTC products).
Initial Dose
60mg after meals and at bedtime
Maintenance Dose
60-125mg taken as needed after meals and at bedtime.
Maximum Dose
480mg per 24 hours (8 tablets of 60mg).
Children's Dosage
Adults and children 12 years and older: chew 1 to 2 tablets (60mg simethicone) as symptoms occur or as directed by a doctor. Do not use in children under 12 years.
Dose Adjustment Notes
No renal or hepatic dose adjustment is required.
How to Take
Chew tablet thoroughly before swallowing. Take after meals and at bedtime, or as directed. Do not swallow whole.
Side Effects
Common Side Effects
Generally well tolerated; no common adverse effects are expected/consistently reported at recommended doses; rare mild GI complaints or hypersensitivity can occur.
Side Effect Frequency
Frequency not well defined; generally none/very rare-rare hypersensitivity reactions have been reported.
Safety & Warnings
Contraindications
Hypersensitivity to simethicone or any excipient/component of the formulation.
Warnings & Precautions
Do not exceed recommended dose; chew thoroughly; seek medical evaluation if symptoms persist/are recurrent or accompanied by alarm features (e.g., severe pain, vomiting, GI bleeding, weight loss).
Age Restriction
No specific age restriction; can be used in children and adults with age-appropriate dosing, but chewable tablets are generally intended for patients able to safely chew (typically ≥2-3 years).
Driving Warning
Safe
Drug Interactions
Drug Interactions
No clinically significant drug interactions are established; if co-administered with other oral medicines, consider separating doses as a precaution.
Interaction Severity
No clinically significant drug interactions are expected; if co-formulated with antacids or other agents, follow that product’s interaction guidance.
Food Interaction
No clinically significant food interaction; for best symptom control take after meals and at bedtime; dietary gas triggers (e.g., carbonated/gas-forming foods) may worsen symptoms but are not a drug interaction.
Alcohol Interaction
Safe
Special Populations
Pregnancy
Safe
Breastfeeding
Safe
Children
Adults and children 12 years and older: chew 1 to 2 tablets (60mg simethicone) as symptoms occur or as directed by a doctor. Do not use in children under 12 years.
Elderly
Standard adult dosing.
Kidney Impairment
No adjustment needed.
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Missed Dose
Usually taken as needed; if using on a schedule, take when remembered unless close to the next dose-then skip; do not double.
Stopping the Medicine
Safe to stop anytime; no tapering required.
Overdose
Overdose is unlikely to be toxic; provide symptomatic/supportive care and seek medical advice/poison center guidance if large ingestion or concerning symptoms occur.
Patient Counseling
Chew thoroughly before swallowing; take after meals and at bedtime as needed; do not exceed the product-labeled maximum daily dose (commonly 500 mg/day for many OTC simethicone products); seek medical advice if symptoms persist, are severe, or are accompanied by alarm features (e.g., weight loss, vomiting, GI bleeding).
Monitoring Requirements
No routine monitoring required.
Pharmacology
Mechanism of Action
Surface-active (antifoaming) agent that lowers surface tension of gas bubbles in the GI tract, causing coalescence and easier elimination by belching or flatus; it does not reduce gas production.
Onset of Action
Rapid-typically within minutes.
Duration of Effect
Short, symptom-driven effect; relief occurs while simethicone is present in the GI lumen and gas/foam is being dispersed (often hours, variable).
Half-Life
Not applicable / not established (simethicone is not systemically absorbed).
Bioavailability
Not systemically absorbed; remains in the GI tract and is eliminated unchanged in feces.
Metabolism
Not metabolized (pharmacologically inert; excreted unchanged in feces).
Excretion
Excreted unchanged in feces.
Protein Binding
Not applicable (no systemic protein binding because it is not absorbed).
Product Information
Available Dosage Forms
For this product (FLATICON): Chewable tablet (oral).
Composition per Dose
Each chewable tablet: 60mg simethicone
Generic Availability
Yes
OTC Alternatives
Other simethicone products (e.g., Gas-X/Mylicon equivalents); nonpharmacologic options include dietary modification; activated charcoal is sometimes used but evidence is limited.
Gi Condition
Flatulence/Gas
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)















